Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Dec 4, 2025 · Filed Dec 5, 2025
A board member of TransDigm Group sold $4.28M of TransDigm Group shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$4,283,402
Shares × reported transaction price
22 days after results of Nov 12, 2025, 61 days before results of Feb 3, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $1,360.10 on Dec 4, 2025, 10% above its 52-week low and 16% below its high, after a 3% rise over the previous 30 trading days
52-week range $1,231.75 (Apr 8, 2025) to $1,620.83 (Jul 30, 2025), 33% of the way up, from 250 adjusted closes. 30 trading days earlier: $1,314.19 on Oct 22, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -4.1% | -0.4% | -3.7% |
| 30 days | +2.8% | +0.9% | +2.0% |
| 90 days | -5.1% | -0.8% | -4.4% |
| 180 days | -10.5% | +8.1% | -18.6% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
TransDigm Group's Co-Chief Operating Officer sold $103K of TransDigm Group shares. Nobody planned it ahead of time.
TransDigm Group's Co-Chief Operating Officer sold $359K of TransDigm Group shares. Nobody planned it ahead of time.